Wednesday, September 28, 2016

Cutivate


Cutivate is a brand name of fluticasone topical, approved by the FDA in the following formulation(s):


CUTIVATE (fluticasone propionate - cream; topical)



  • Manufacturer: FOUGERA PHARMS

    Approval date: December 18, 1990

    Strength(s): 0.05% [RLD][AB]

CUTIVATE (fluticasone propionate - lotion; topical)



  • Manufacturer: FOUGERA PHARMS

    Approval date: March 31, 2005

    Strength(s): 0.05% [RLD][AB]

CUTIVATE (fluticasone propionate - ointment; topical)



  • Manufacturer: FOUGERA PHARMS

    Approval date: December 14, 1990

    Strength(s): 0.005% [RLD][AB]

Has a generic version of Cutivate been approved?


A generic version of Cutivate has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Cutivate and have been approved by the FDA:


fluticasone propionate cream; topical



  • Manufacturer: G AND W LABS

    Approval date: June 30, 2006

    Strength(s): 0.05% [AB]


  • Manufacturer: NESHER PHARMS

    Approval date: September 10, 2004

    Strength(s): 0.05% [AB]


  • Manufacturer: PERRIGO NEW YORK

    Approval date: May 14, 2004

    Strength(s): 0.05% [AB]


  • Manufacturer: TOLMAR

    Approval date: May 14, 2004

    Strength(s): 0.05% [AB]

fluticasone propionate lotion; topical



  • Manufacturer: GLENMARK GENERICS

    Approval date: May 2, 2011

    Strength(s): 0.05% [AB]

fluticasone propionate ointment; topical



  • Manufacturer: G AND W LABS

    Approval date: March 3, 2006

    Strength(s): 0.005% [AB]


  • Manufacturer: PERRIGO NEW YORK

    Approval date: May 14, 2004

    Strength(s): 0.005% [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Cutivate. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Fluticasone lotion having improved vasoconstrictor activity
    Patent 7,300,669
    Issued: November 27, 2007
    Inventor(s): Dow; Gordon J. & Johnson; Keith Arthur & Kelly; Frances Furr & Lathrop; Robert William & Rajagopalan; Rukmini
    Assignee(s): Altana Inc.
    A fluticasone lotion having improved vasoconstrictor and anti-inflammatory activity and higher than expected potency. The fluticasone lotion contains 0.05 weight percent fluticasone propionate and an oil-in-water vehicle that includes excipients. The fluticasone lotion is unexpectedly efficacious while exhibiting an improved safety profile.
    Patent expiration dates:

    • October 20, 2019
      ✓ 
      Patent use: RELIEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF ATOPIC DERMATITIS IN PATIENTS ONE YEAR OF AGE OR OLDER
      ✓ 
      Drug product



See also...

  • Cutivate Cream Consumer Information (Wolters Kluwer)
  • Cutivate Lotion Consumer Information (Wolters Kluwer)
  • Cutivate Consumer Information (Cerner Multum)
  • Cutivate Advanced Consumer Information (Micromedex)
  • Fluticasone Cream Consumer Information (Wolters Kluwer)
  • Fluticasone Lotion Consumer Information (Wolters Kluwer)
  • Fluticasone topical Consumer Information (Cerner Multum)
  • Fluticasone Topical application Advanced Consumer Information (Micromedex)

No comments:

Post a Comment